Improving drug allergy management in Australia: education, communication and accurate information

A drug allergy label is often applied to a patient after an adverse drug reaction (ADR), usually resulting in subsequent avoidance of the drug and related drugs. Recent attention has focused on antibiotic allergy labels and the benefits of delabelling.1 But drug allergy labels, which occur in up to 35% of patient electronic health records (EHRs), encompass all types of medications, with antibiotics, opiates and nonsteroidal antiinflammatory drugs being among the most common (Box 1).2 Accurate and effective communication of drug allergy is crucial for safe prescribing, including sufficient information to enable assessment of the risk of reexposure compared with the risk of withholding the index drug and related drugs.

[1]  M. Pérault-Pochat,et al.  Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012 , 2018, Allergy.

[2]  E. Phillips,et al.  How antibiotic allergy labels may be harming our most vulnerable patients , 2018, The Medical journal of Australia.

[3]  G. Caughey,et al.  Documentation of penicillin adverse drug reactions in electronic health records: inconsistent use of allergy and intolerance labels , 2017, Internal medicine journal.

[4]  T. Cook,et al.  UK anaesthetists’ perspectives and experiences of severe perioperative anaphylaxis: NAP6 baseline survey† , 2017, British journal of anaesthesia.

[5]  E. Phillips,et al.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. , 2017, The journal of allergy and clinical immunology. In practice.

[6]  E. Phillips,et al.  Return to sender: the need to re‐address patient antibiotic allergy labels in Australia and New Zealand , 2016, Internal medicine journal.

[7]  D. Bates,et al.  Drug allergies documented in electronic health records of a large healthcare system , 2016, Allergy.

[8]  R. Mullins,et al.  Increases in anaphylaxis fatalities in Australia from 1997 to 2013 , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  J. Trubiano,et al.  Old but not forgotten: Antibiotic allergies in General Medicine (the AGM Study) , 2016, The Medical journal of Australia.

[10]  A. Robicsek,et al.  Documenting Penicillin Allergy: The Impact of Inconsistency , 2016, PloS one.

[11]  Kimberly G Blumenthal,et al.  Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[12]  D. Hooper,et al.  Impact of a Clinical Guideline for Prescribing Antibiotics to Inpatients with Reported Penicillin or Cephalosporin Allergies , 2015 .

[13]  Kimberly G Blumenthal,et al.  Effect of a drug allergy educational program and antibiotic prescribing guideline on inpatient clinical providers' antibiotic prescribing knowledge. , 2014, Journal of Allergy and Clinical Immunology: In Practice.

[14]  S. Johansson,et al.  The pholcodine Case. Cough Medicines, IgE-Sensitization, and Anaphylaxis: A Devious Connection , 2012, The World Allergy Organization journal.

[15]  M. Wiese,et al.  Oral drug challenges in non‐steroidal anti‐inflammatory drug‐induced urticaria, angioedema and anaphylaxis , 2012, Internal medicine journal.

[16]  C. Katelaris,et al.  'Iodine allergy' label is misleading , 2009 .

[17]  D. Alexander,et al.  Impact of junior doctor education on drug allergy documentation. , 2005, Annals of the Royal College of Surgeons of England.